Jennifer L. Yori, Ph.D.
Affiliations: | 2011 | Pharmacology | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Pharmacology, Oncology, Cell BiologyGoogle:
"Jennifer Yori"Parents
Sign in to add mentor| Ruth A. Keri | grad student | 2011 | Case Western | |
| (Discerning the role of Kruppel-like factor 4 in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sahni JM, Gayle SS, Bonk KLW, et al. (2020) Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266 |
| Sahni JM, Gayle SS, Bonk KLW, et al. (2020) Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266 |
| Liao P, Yori J, Keri R, et al. (2018) Abstract 2262: Inference of kinase activity for cancer phosphoproteomics using substrate prediction scores Cancer Research. 78: 2262-2262 |
| Sahni JM, Gayle SS, Weber-Bonk KL, et al. (2016) Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of Aurora kinases. The Journal of Biological Chemistry |
| Yori JL, Lozada KL, Seachrist DD, et al. (2014) Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression. Cancer Research. 74: 4762-71 |
| Yori JL, Lozada K, Seachrist DD, et al. (2013) Abstract LB-221: Inhibition of rapamycin-induced feedback activation of AKT with dasatinib induces complete tumor regression in a preclinical model of breast cancer. Cancer Research. 73 |
| Yori JL, Seachrist DD, Johnson E, et al. (2011) Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (New York, N.Y.). 13: 601-10 |
| Yori JL, Johnson E, Zhou G, et al. (2010) Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. The Journal of Biological Chemistry. 285: 16854-63 |